智通财经网·2025-05-06 04:06Group 1 - The Hang Seng Index rose by 0.69%, gaining 154 points to reach 22,658 points, while the Hang Seng Tech Index fell by 0.10% [1] - The Hong Kong stock market saw a trading volume of HKD 124.5 billion in the morning session [1] - Airline stocks experienced significant gains, with China National Aviation (00753) up 7.31%, China Southern Airlines (01055) up 8.44%, and China Eastern Airlines (00670) up 8.58%, driven by double-digit growth in passenger traffic during the May Day holiday and expectations of falling oil prices supporting airline performance [1] Group 2 - Ant Group's Ant International is reportedly planning to list in Hong Kong, leading to a nearly 20% rise in Yao Cai Securities [1] - Alibaba-related stocks also saw increases, with China Dynamics (03818) up 6.41% and Yunfeng Financial (00376) up over 11.72% [1] - Shandong Molong (00568) surged by 50% after being added to the Hong Kong Stock Connect eligible securities list [1] Group 3 - The rare earth sector showed strength, with Jinli Permanent Magnet (06680) rising over 10% due to export restrictions causing some rare earth metals to surge over 200% [1] - Dongyue Group (00189) increased by 6.65% as the refrigerant consumption is expected to enter a traditional peak season, potentially leading to a new round of price increases in Q2 [1] - Chow Tai Fook (01929) rose by 5.85%, reaching a new high in over a year, following target price upgrades from several major brokerages [1] Group 4 - Guofu Hydrogen Energy (02582) increased by 6.57% after participating in the compilation of the "Industrial By-product Hydrogen Carbon Emission Accounting Method," achieving significant results in international cooperation [2] - MGM China (02282) led the gaming sector with a 7.96% increase, as visitor numbers to Macau during the May Day Golden Week exceeded expectations, and April's gaming revenue in Macau rose by 1.7% year-on-year [3] - CRO sector stocks fell in the morning session, with Weiya Bio (01873) down 5.88% and WuXi AppTec (02359) down 2.33%, following U.S. President Trump's announcement of upcoming tariff measures on pharmaceutical products [3]